The new agreement with Ophthalmic Instrument Company will bring NovaBay’s Avenova to patients throughout New Zealand
EMERYVILLE, Calif., Sept 3 (Bernama-BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today announced that the company’s breakthrough prescription daily eyelid and lash hygiene product, Avenova™, will be marketed in New Zealand through a partnership with Ophthalmic Instrument Company.
http://mrem.bernama.com/viewsm.php?idm=25198
No comments:
Post a Comment